280 related articles for article (PubMed ID: 31994461)
21. Effects of cell-penetrating peptides on transduction efficiency of PEGylated adenovirus.
Nigatu AS; Vupputuri S; Flynn N; Ramsey JD
Biomed Pharmacother; 2015 Apr; 71():153-60. PubMed ID: 25960231
[TBL] [Abstract][Full Text] [Related]
22. Rational design of CPP-based drug delivery systems: considerations from pharmacokinetics.
Mickan A; Sarko D; Haberkorn U; Mier W
Curr Pharm Biotechnol; 2014; 15(3):200-9. PubMed ID: 25312539
[TBL] [Abstract][Full Text] [Related]
23. Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections.
Khairkhah N; Namvar A; Bolhassani A
Mol Biotechnol; 2023 Sep; 65(9):1387-1402. PubMed ID: 36719639
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides.
Lindberg S; Copolovici DM; Langel U
Ther Deliv; 2011 Jan; 2(1):71-82. PubMed ID: 22833926
[TBL] [Abstract][Full Text] [Related]
25. Cell-penetrating peptides as delivery enhancers for vaccine.
Jiang Y; Li M; Zhang Z; Gong T; Sun X
Curr Pharm Biotechnol; 2014; 15(3):256-66. PubMed ID: 25142954
[TBL] [Abstract][Full Text] [Related]
26. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
27. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
28. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
Jobin ML; Alves ID
Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
[TBL] [Abstract][Full Text] [Related]
29. Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development.
Dowaidar M
Cell Signal; 2024 May; 117():111116. PubMed ID: 38408550
[TBL] [Abstract][Full Text] [Related]
30. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
Kurzawa L; Pellerano M; Morris MC
Biochim Biophys Acta; 2010 Dec; 1798(12):2274-85. PubMed ID: 20188697
[TBL] [Abstract][Full Text] [Related]
31. The role of cell-penetrating peptides in potential anti-cancer therapy.
Zhou M; Zou X; Cheng K; Zhong S; Su Y; Wu T; Tao Y; Cong L; Yan B; Jiang Y
Clin Transl Med; 2022 May; 12(5):e822. PubMed ID: 35593206
[TBL] [Abstract][Full Text] [Related]
32. Cell-Penetrating Peptides as a Potential Drug Delivery System for Effective Treatment of Diabetes.
Korivi M; Huang YW; Liu BR
Curr Pharm Des; 2021; 27(6):816-825. PubMed ID: 33076803
[TBL] [Abstract][Full Text] [Related]
33. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
34. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
Dissanayake S; Denny WA; Gamage S; Sarojini V
J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
[TBL] [Abstract][Full Text] [Related]
35. Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides.
Nhàn NTT; Maidana DE; Yamada KH
Cells; 2023 Apr; 12(7):. PubMed ID: 37048144
[TBL] [Abstract][Full Text] [Related]
36. Cell penetrating peptides: A concise review with emphasis on biomedical applications.
Derakhshankhah H; Jafari S
Biomed Pharmacother; 2018 Dec; 108():1090-1096. PubMed ID: 30372809
[TBL] [Abstract][Full Text] [Related]
37. Arginine-rich peptides: methods of translocation through biological membranes.
Futaki S; Hirose H; Nakase I
Curr Pharm Des; 2013; 19(16):2863-8. PubMed ID: 23140459
[TBL] [Abstract][Full Text] [Related]
38. Cell penetrating peptides are versatile tools for enhancing multimodal uptake into cells from pest insects.
Darif N; Vogelsang K; Vorgia E; Schneider D; Deligianni E; Geibel S; Vontas J; Denecke S
Pestic Biochem Physiol; 2023 Feb; 190():105317. PubMed ID: 36740333
[TBL] [Abstract][Full Text] [Related]
39. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
Shi NQ; Qi XR; Xiang B; Zhang Y
J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
[TBL] [Abstract][Full Text] [Related]
40. Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells.
Ruczynski J; Wierzbicki PM; Kogut-Wierzbicka M; Mucha P; Siedlecka-Kroplewska K; Rekowski P
Folia Histochem Cytobiol; 2014; 52(4):257-69. PubMed ID: 25530464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
